Aarhus University Seal / Aarhus Universitets segl

Venøse tromboser hos børn

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • Ruta Tuckuviene, Denmark
  • Søren Paaske Johnsen, Denmark
  • Jon Helgestad, Denmark
  • Jørgen Ingerslev, Denmark
  • Søren Risom Kristensen, Denmark
  • Børneafdelingen, Aalborg Sygehus
  • FBE Klinisk Biokemisk Syd, Aalborg Sygehus
  • Department of clinical biochemistry
  • Department of Clinical Epidemiology
  • Kardiovaskulært Forskningscenter, Aalborg Sygehus
Venous thromboembolism is a rare condition in children, but the incidence appears to be increasing. Newborns and teenagers are at the highest risk of thrombosis, which is often triggered by a combination of risk factors, in particular: infection, central venous line or chemotherapy. The impact of thrombophilia is uncertain. International guidelines recommend screening for thrombophilia as part of the diagnostic set-up in children with thrombosis. Treatment of paediatric thrombosis with low-molecular-weight heparin appears safe, but the effectiveness remains to be established.
Udgivelsesdato: 2008-Oct-20
Original languageDanish
JournalUgeskrift for Laeger
Pages (from-to)3424-9
Number of pages5
Publication statusPublished - 2008

    Research areas

  • Adolescent, Child, Fibrinolytic Agents, Heparin, Low-Molecular-Weight, Humans, Incidence, Infant, Newborn, Risk Factors, Sinus Thrombosis, Intracranial, Thromboembolism, Thrombophilia, Venous Thrombosis

See relations at Aarhus University Citationformats

ID: 14799982